JD Capital-invested Hongtu Logistics and Charioteer Pharmaceutical Listed on NEEQ

2015-01-21

Sichuan Hongtu Logistics Co.,Ltd. (Hongtu Logistics, 831733) and Zhejiang Charioteer Pharmaceutical Co., Ltd. (Charioteer Pharmaceutical, 831920), both invested by JD Capital, were officially listed on the National Equities Exchange and Quotations (NEEQ) on January 5 and 20 respectively. 

Since its establishment in 2005, Hongtu Logistics has been engaged in model innovation, making proactive efforts in improving logistics with information technology. For the first time, it proposed a “3+4” service model based on the complete supply chain. Hongtu mainly provides comprehensive logistics services, including third-party basic logistics and supply chain value-added logistics. It has also built an IT management system for its clients—the third-party logistics supply chain management information platform, which contributed to the rapid growth of third-party logistics business. In the meantime, Hongtu seeks to transform from a third-party logistics service provider to a comprehensive one and plans to create a new operation model with three key segments (comprehensive logistics service, public logistics park and logistics information e-commerce platform) at the core. 

Founded in 1998, Charioteer Pharmaceutical has three fully-owned subsidiaries, all national key high-tech companies. It mainly focuses on the R&D, production and sales of chemical API (Active Pharmaceutical Ingredient) and medical intermediates, mostly used for the production of preparations (anti-inflammation & analgesia, anti-virus, anti-tumor and cardiovascular). With the world’s highest sales and the most advanced technology, the Headquarter mainly produces nucleoside anti-virus products, anti-inflammation & analgesia API and intermediates. The company has acquired ISO9001/ISO14001/OHS18001 certifications with multiple products certificated by national GMP, European GMP, FDA and EU COS.

JD Capital invested in Hongtu Logistics in 2012 and Charioteer Pharmaceutical in 2013. By far, 20 of JD Capital-invested companies have gone public on the NEEQ.